ORGANOGENESIS HOLDINGS INC. Payments for Derivative Instrument, Financing Activities
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Payments for Derivative Instrument, Financing Activities of $6.76 million for the 12-month period ending 2019-12-31, per its 10-K filed 2022-03-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForDerivativeInstrumentFinancingActivities · last filed 2022-03-01
- ORGANOGENESIS HOLDINGS INC. payments for derivative instrument, financing activities for the quarter ending 2019-12-31 was $0.00.
- ORGANOGENESIS HOLDINGS INC. payments for derivative instrument, financing activities for the quarter ending 2019-09-30 was $0.00.
- ORGANOGENESIS HOLDINGS INC. payments for derivative instrument, financing activities for the quarter ending 2019-06-30 was $0.00.
- ORGANOGENESIS HOLDINGS INC. payments for derivative instrument, financing activities for the quarter ending 2019-03-31 was $6.76M.
- ORGANOGENESIS HOLDINGS INC. payments for derivative instrument, financing activities for fiscal 2019 was $6.76M.
| Period end | Payments for Derivative Instrument, Financing Activities 3 month | Payments for Derivative Instrument, Financing Activities 6 month | Payments for Derivative Instrument, Financing Activities 9 month | Payments for Derivative Instrument, Financing Activities 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $6.76M 10-K · filed 2022-03-01 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $6.76M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $6.76M 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $6.76M 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |